ProcureHub · Indirect & Services · Global

Translational Research Services: Market Size & Forecast 2026

The global translational research services market sits at approximately USD 92 billion in 2025 (base year), growing at a 7-year CAGR of 8.5% to reach roughly USD 163 billion by 2032. Demand is structurally supported by rising pharma R&D outsourcing intensity (currently ~45% of clinical development spend), accelerating biotech funding cycles, and a regulatory environment that has tightened under ICH E6(R3) GCP and FDA 21 CFR 312 expectations for risk-based monitoring. Supply remains moderately concentrated: the top-6 CROs and translational service providers hold an estimated 55-65% of global revenue. > Synthesised from secondary and publicly verifiable sources via Claight Category Watch:

Market size · 2025
$92.0bn
CAGR · 2025–2030
8.5%
Forecast · 2030
$138.3bn
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and CAGR extracted from the published Claight report; figures match the report..
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2025 base: $92.0bn2032 est: $162.9bn
Read the full Translational Research Services report →
Talk to a Claight analyst
Do you want to research Translational Research Services?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.